Regulation of Globin Gene Switching by O-GlcNAc Post-Translational Modification
O-GlcNAc 翻译后修饰调控球蛋白基因转换
基本信息
- 批准号:8610686
- 负责人:
- 金额:$ 26.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-01-01 至 2016-12-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAdverse effectsAffectAfrican AmericanBinding SitesBiochemicalBiologicalCell Culture TechniquesCell CycleCell physiologyCellsChromatin Remodeling FactorComplexCooley&aposs anemiaCytoplasmic ProteinDNA BindingDNA-Binding ProteinsDataDevelopmentDiseaseDrosophila genusEnzymesErythrocytesErythroidErythroid CellsErythropoiesisFetal HemoglobinFetal LiverFunctional disorderGene ExpressionGene SilencingGenesGenetic TranscriptionGlobinGlucosamineGoalsHemoglobinopathiesHereditary DiseaseHomeobox GenesHumanKnock-outKnockout MiceKnowledgeLeadMediatingModelingModificationMolecularMolecular TargetMusNuRD complexNuclear ProteinsO-GlcNAc transferaseOutcomeOutcome StudyPathway interactionsPatientsPhysiologicalPlayPolycombPost-Translational Protein ProcessingPromoter RegionsProteinsRegulationRelative (related person)RepressionRepressor ProteinsResearchRoleSerineSickle Cell AnemiaSiteSwitch GenesSystemTestingThalassemiaTherapeuticThreonineTranscription CoactivatorTranscription Repressor/CorepressorTransgenic MiceTransgenic OrganismsTranslationsUp-Regulationbasebiological adaptation to stresschromatin immunoprecipitationdrug developmenteffective therapyfetalgain of functiongene repressionhuman GATA1 proteinin vivoloss of functionmouse modelnew therapeutic targetnovelnull mutationpeptide O-linked N-acetylglucosamine-beta-N-acetylglucosaminidasepromoterpublic health relevancetranscription factor
项目摘要
DESCRIPTION (provided by applicant): Understanding the molecular mechanisms underlying the human ?- to ¿-globin gene switch has long been recognized as important in the treatment of hemoglobinopathies such as sickle cell disease (SCD), Cooley's anemia and ¿-thalassemias, since a wealth of evidence demonstrates that increased fetal hemoglobin (HbF) significantly decreases the pathophysiology associated with these diseases in patients. Our goal in this study is to understand the role of post-translation modifications (PTMs) of transcription factors involved in ?-globin gene silencing during the adult definitive erythropoiesis. Our clinica goal is to identify new molecular targets based on the outcome of this study that can be modulated therapeutically for up-regulation of ?-globin synthesis to treat these diseases. We recently demonstrated that one mode of ?-globin silencing occurs at the GATA binding sites located at -566 or -567 relative to the A?-globin or G?-globin gene CAP sites, respectively, and is
mediated through the DNA-binding moiety GATA-1 and its recruitment of co-repressor partners, FOG-1 and Mi2, a component of the NuRD chromatin remodeling complex. Post-translational modifications of transcription factors may play a critical role in regulating the formation of transcriptional repressor complexes or activator complexes, particularly when both types of complexes might utilize the same DNA-binding protein, as is the case for GATA-1 in erythroid cells. We propose that the O-GlcNAcylation (O-GlcNAc) PTM is involved in regulating ?-globin transcription by controlling assembly of the GATA-1-FOG-1-Mi2 (NuRD) transcriptional repressor complex upstream of the ?-globin genes. A single Specific Aim will test the hypothesis that O-GlcNAcylation of GATA-1-FOG-1-Mi2 (NuRD) transcription/chromatin remodeling factors regulates their participation in a multi-protein repressor complex. In Specific Aim 1a, we will investigate the regulation of the ?-globin genes by O-GlcNAcylation. Chromatin immunoprecipitation (ChIP) analyses will be utilized to examine the spatial and temporal arrangement of the O-GlcNAc cycling enzymes, O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), the GATA-1-FOG-1-Mi2 axis of proteins at the A?- globin promoter and the O-GlcNAc status of the promoter itself in cell cultures following terminal differentiation or induction of globin gene expression, with or without OGT/OGA knockdown or OGA inhibition, or in ¿-YAC transgenic mice during fetal liver definitive erythropoiesis. In Specific Aim 1b, we will determine whether O-GlcNAc regulates ¿-like globin gene expression during erythropoietic development in vivo in erythroid-specific floxed OGT conditional knockout ¿-YAC mice, or in OGT or OGA enforced-expression ¿-YAC bi-transgenic (bigenic) mice. Our proposed studies represent a new avenue of research in the globin gene switching field. The knowledge we gain from these studies will reveal novel therapeutic targets for which highly-specific treatments may be developed to increase HbF for the treatment of these red blood cells diseases without the side-effects associated with broad-spectrum therapies.
描述(由申请人提供):了解人类的分子机制?长期以来,人们一直认为-到-珠蛋白基因开关在治疗血红蛋白病(如镰状细胞病(SCD)、库利贫血(Cooley’s anemia)和-地中海贫血(-thalassemia)中发挥着重要作用,因为大量证据表明,胎儿血红蛋白(HbF)的增加显著降低了患者与这些疾病相关的病理生理学。我们在这项研究中的目标是了解转录因子的翻译后修饰(PTMs)的作用。-珠蛋白基因在成人终性红细胞生成过程中的沉默。我们的临床目标是根据这项研究的结果确定新的分子靶点,这些靶点可以通过治疗性调节来上调?-珠蛋白合成来治疗这些疾病我们最近展示了?-珠蛋白沉默发生在GATA结合位点-566或-567处。-球蛋白还是G?-珠蛋白基因CAP位点分别为,和
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH R PETERSON其他文献
KENNETH R PETERSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH R PETERSON', 18)}}的其他基金
Regulation of Globin Gene Switching by O-GlcNAc Post-Translational Modification
O-GlcNAc 翻译后修饰调控球蛋白基因转换
- 批准号:
8784216 - 财政年份:2014
- 资助金额:
$ 26.27万 - 项目类别:
Regulation of Globin Gene Switching by O-GlcNAc Post-Translational Modification
O-GlcNAc 翻译后修饰调控球蛋白基因转换
- 批准号:
8995201 - 财政年份:2014
- 资助金额:
$ 26.27万 - 项目类别:
Mechanisms of HbF Activation by Non-deletional HPFH
非缺失 HPFH 激活 HbF 的机制
- 批准号:
8721479 - 财政年份:2013
- 资助金额:
$ 26.27万 - 项目类别:
Mechanisms of HbF Activation by Non-deletional HPFH
非缺失 HPFH 激活 HbF 的机制
- 批准号:
8854128 - 财政年份:2013
- 资助金额:
$ 26.27万 - 项目类别:
Mechanisms of HbF Activation by Non-deletional HPFH
非缺失 HPFH 激活 HbF 的机制
- 批准号:
8578291 - 财政年份:2013
- 资助金额:
$ 26.27万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 26.27万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 26.27万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 26.27万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 26.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 26.27万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 26.27万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 26.27万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 26.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 26.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 26.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)